Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for Excessive Daytime Sleepiness in Parkinson's Disease
NCT01066442Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Mar 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitolisant in Parkinson's disease (PD), sponsored by Bioprojet. Started Mar 2010; status: completed.
02
Drugs
pitolisant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01066442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066442.